| Authors: |
Haas L; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria., Elewaut A; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria., Gerard CL; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Umkehrer C; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria., Leiendecker L; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria., Pedersen M; Institute of Cancer Research, London, UK., Krecioch I; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria., Hoffmann D; Institute of Molecular Biotechnology, Vienna Biocenter, Vienna, Austria., Novatchkova M; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria., Kuttke M; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.; Institute of Vascular Biology and Thrombosis Research, Medical University of Vienna, Vienna, Austria., Neumann T; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria., da Silva IP; Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia., Witthock H; Institute of Cancer Research, London, UK., Cuendet MA; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Molecular Modeling Group, Swiss Institute of Bioinformatics, UNIL Sorge, Lausanne, Switzerland.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA., Carotta S; Boehringer Ingelheim RCV GmBH & Co KG, Vienna, Austria., Harrington KJ; Institute of Cancer Research, London, UK., Zuber J; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria., Scolyer RA; Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital & NSW Health Pathology, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore Hospital, Sydney, New South Wales, Australia.; Mater Hospital, North Sydney, New South Wales, Australia., Wilmott JS; Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia., Michielin O; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Molecular Modeling Group, Swiss Institute of Bioinformatics, UNIL Sorge, Lausanne, Switzerland., Vanharanta S; MRC Cancer Unit, University of Cambridge, Cambridge, UK., Wiesner T; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Obenauf AC; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria. anna.obenauf@imp.ac.at. |
